Eptastigmine restores the aged rat's normal cortical spectral power pattern

Daniela Braida, Francesco Ottonello, Mariaelvina Sala

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We studied the ability of eptastigmine, a second-generation acetylcholinesterase inhibitor (AChEI), to reverse the age-related increase of electroencephalogram (EEG) mean cortical spectral power in slow-wave δ activity and decrease in fast-wave α and β activity. The relative basal spectral power profile evaluated for 50 min of the old (27-30 months) in comparison to young (4-6 months) awake rats was consistently different, showing a significant increase in δ (0.2-4.0 Hz) frequency and a significant decrease of a (8.2-13.0 Hz) and β (13.2-25.0) bands. When 0.5, 1, 2, 4 mg kg-1 of eptastigmine were administered orally as single increasing doses for old and young rats 2 h prior to the EEG recordings, lasting 2 h, the relative mean spectral power difference (Δ%) showed a linear log dose-related decrease in δ activity and a progressive increase in α and β activity in old rats. Compared to vehicle, in young rats, the eptastigmine dose of 0.5 mg kg-1 produced a significant decrease in δ activity and an increase in β activity. The spontaneous motor activity, evaluated through cumulative horizontal and vertical counts for 30 min in old rats was significantly decreased when compared to young rats. Single oral treatment with eptastigmine (0.5 mg kg-1 for young and 2 mg kg-1 for old rats) given 2 h before the test did not significantly change motor activity in comparison to vehicle group of the same age. These results suggest a possible strategy to alleviate the severe slowing of neocortical EEG accompanying the cognitive decline. (C) 2000 Academic Press.

Original languageEnglish
Pages (from-to)495-500
Number of pages6
JournalPharmacological Research
Volume42
Issue number5
DOIs
Publication statusPublished - 2000

Fingerprint

Electroencephalography
Motor Activity
Aptitude
Cholinesterase Inhibitors
physostigmine heptyl
Power (Psychology)
Age Groups
Therapeutics
Cognitive Dysfunction

Keywords

  • Acetylcholinesterase inhibitor
  • Electroencephalogram
  • Eptastigmine
  • Spontaneous motor activity
  • Young vs aged rats

ASJC Scopus subject areas

  • Pharmacology

Cite this

Eptastigmine restores the aged rat's normal cortical spectral power pattern. / Braida, Daniela; Ottonello, Francesco; Sala, Mariaelvina.

In: Pharmacological Research, Vol. 42, No. 5, 2000, p. 495-500.

Research output: Contribution to journalArticle

Braida, Daniela ; Ottonello, Francesco ; Sala, Mariaelvina. / Eptastigmine restores the aged rat's normal cortical spectral power pattern. In: Pharmacological Research. 2000 ; Vol. 42, No. 5. pp. 495-500.
@article{7848af350dfe4ca29ae5f8bf067a95aa,
title = "Eptastigmine restores the aged rat's normal cortical spectral power pattern",
abstract = "We studied the ability of eptastigmine, a second-generation acetylcholinesterase inhibitor (AChEI), to reverse the age-related increase of electroencephalogram (EEG) mean cortical spectral power in slow-wave δ activity and decrease in fast-wave α and β activity. The relative basal spectral power profile evaluated for 50 min of the old (27-30 months) in comparison to young (4-6 months) awake rats was consistently different, showing a significant increase in δ (0.2-4.0 Hz) frequency and a significant decrease of a (8.2-13.0 Hz) and β (13.2-25.0) bands. When 0.5, 1, 2, 4 mg kg-1 of eptastigmine were administered orally as single increasing doses for old and young rats 2 h prior to the EEG recordings, lasting 2 h, the relative mean spectral power difference (Δ{\%}) showed a linear log dose-related decrease in δ activity and a progressive increase in α and β activity in old rats. Compared to vehicle, in young rats, the eptastigmine dose of 0.5 mg kg-1 produced a significant decrease in δ activity and an increase in β activity. The spontaneous motor activity, evaluated through cumulative horizontal and vertical counts for 30 min in old rats was significantly decreased when compared to young rats. Single oral treatment with eptastigmine (0.5 mg kg-1 for young and 2 mg kg-1 for old rats) given 2 h before the test did not significantly change motor activity in comparison to vehicle group of the same age. These results suggest a possible strategy to alleviate the severe slowing of neocortical EEG accompanying the cognitive decline. (C) 2000 Academic Press.",
keywords = "Acetylcholinesterase inhibitor, Electroencephalogram, Eptastigmine, Spontaneous motor activity, Young vs aged rats",
author = "Daniela Braida and Francesco Ottonello and Mariaelvina Sala",
year = "2000",
doi = "10.1006/phrs.2000.0732",
language = "English",
volume = "42",
pages = "495--500",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",
number = "5",

}

TY - JOUR

T1 - Eptastigmine restores the aged rat's normal cortical spectral power pattern

AU - Braida, Daniela

AU - Ottonello, Francesco

AU - Sala, Mariaelvina

PY - 2000

Y1 - 2000

N2 - We studied the ability of eptastigmine, a second-generation acetylcholinesterase inhibitor (AChEI), to reverse the age-related increase of electroencephalogram (EEG) mean cortical spectral power in slow-wave δ activity and decrease in fast-wave α and β activity. The relative basal spectral power profile evaluated for 50 min of the old (27-30 months) in comparison to young (4-6 months) awake rats was consistently different, showing a significant increase in δ (0.2-4.0 Hz) frequency and a significant decrease of a (8.2-13.0 Hz) and β (13.2-25.0) bands. When 0.5, 1, 2, 4 mg kg-1 of eptastigmine were administered orally as single increasing doses for old and young rats 2 h prior to the EEG recordings, lasting 2 h, the relative mean spectral power difference (Δ%) showed a linear log dose-related decrease in δ activity and a progressive increase in α and β activity in old rats. Compared to vehicle, in young rats, the eptastigmine dose of 0.5 mg kg-1 produced a significant decrease in δ activity and an increase in β activity. The spontaneous motor activity, evaluated through cumulative horizontal and vertical counts for 30 min in old rats was significantly decreased when compared to young rats. Single oral treatment with eptastigmine (0.5 mg kg-1 for young and 2 mg kg-1 for old rats) given 2 h before the test did not significantly change motor activity in comparison to vehicle group of the same age. These results suggest a possible strategy to alleviate the severe slowing of neocortical EEG accompanying the cognitive decline. (C) 2000 Academic Press.

AB - We studied the ability of eptastigmine, a second-generation acetylcholinesterase inhibitor (AChEI), to reverse the age-related increase of electroencephalogram (EEG) mean cortical spectral power in slow-wave δ activity and decrease in fast-wave α and β activity. The relative basal spectral power profile evaluated for 50 min of the old (27-30 months) in comparison to young (4-6 months) awake rats was consistently different, showing a significant increase in δ (0.2-4.0 Hz) frequency and a significant decrease of a (8.2-13.0 Hz) and β (13.2-25.0) bands. When 0.5, 1, 2, 4 mg kg-1 of eptastigmine were administered orally as single increasing doses for old and young rats 2 h prior to the EEG recordings, lasting 2 h, the relative mean spectral power difference (Δ%) showed a linear log dose-related decrease in δ activity and a progressive increase in α and β activity in old rats. Compared to vehicle, in young rats, the eptastigmine dose of 0.5 mg kg-1 produced a significant decrease in δ activity and an increase in β activity. The spontaneous motor activity, evaluated through cumulative horizontal and vertical counts for 30 min in old rats was significantly decreased when compared to young rats. Single oral treatment with eptastigmine (0.5 mg kg-1 for young and 2 mg kg-1 for old rats) given 2 h before the test did not significantly change motor activity in comparison to vehicle group of the same age. These results suggest a possible strategy to alleviate the severe slowing of neocortical EEG accompanying the cognitive decline. (C) 2000 Academic Press.

KW - Acetylcholinesterase inhibitor

KW - Electroencephalogram

KW - Eptastigmine

KW - Spontaneous motor activity

KW - Young vs aged rats

UR - http://www.scopus.com/inward/record.url?scp=0033736146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033736146&partnerID=8YFLogxK

U2 - 10.1006/phrs.2000.0732

DO - 10.1006/phrs.2000.0732

M3 - Article

VL - 42

SP - 495

EP - 500

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 5

ER -